Download


Lipid Profile
Investigation Result Units Biological Reference Interval

Cholesterol - Total 210.8 mg/dl 0 - 239
• Sample Type: Serum.
• Method: CHOD-PAP.
Triglycerides 168 mg/dl Normal : < 150
Borderline : 150 - 199
High : 200 - 499
• Sample Type: Serum.
• Method: GPO-PAP/Enzymatic Colorimetric.
Cholesterol HDL Direct 27.1 mg/dl 40 - 60
• Sample Type: Serum.
• Method: Direct method / Enzymatic colorimetric.
Cholesterol LDL Direct 150.1 mg/dl Optimal: < 100
Near or above optimal: 100 -129
Borderline high : 130 -159
High : 160 -189
Very high : > 190
• Sample Type: Serum.
• Method: Calculated.
VLDL-Cholesterol 33.6 mg/dl 0 - 30
• Sample Type: Serum.
• Method: Calculated.
Cholesterol/HDL Ratio 7.78 mg/dl 3.5 - 5
• Sample Type: Serum.
• Method: Calculated.
Lipid Profile
Investigation Result Units Biological Reference Interval

LDL/HDL Ratio 5.54 mg/dl 2.5 - 3.5
• Sample Type: Serum.
• Method: Calculated.

• Disclaimer : 1) The above result relate only to the specimens received and tested in laboratory and should be always correlate with clinical findings and other laboratory markers. Clinical Significance: i) Cholesterol Total: Cholesterol is a fatty substance that is essential for building cell membranes and producing certain hormones. Elevated total cholesterol levels can contribute to the formation of plaques in the arteries, increasing the risk of atherosclerosis and cardiovascular diseases. ii) Triglycerides: Elevated triglyceride levels are associated with an increased risk of cardiovascular disease. High triglycerides are often seen in conjunction with other risk factors, such as obesity and insulin resistance. iii) Cholesterol HDL: High Density Lipoprotein: HDL cholesterol is often referred to as "good" cholesterol because higher levels are associated with a lower risk of cardiovascular disease. HDL helps remove LDL cholesterol from the bloodstream. iv) Cholesterol LDL: Low Density Lipoprotein: LDL cholesterol is often referred to as "bad" cholesterol because high levels are associated with an increased risk of atherosclerosis and coronary artery disease. Lowering LDL cholesterol is a primary goal in cardiovascular risk management. v) VLDL-Cholesterol: VLDL cholesterol, or very low density lipoprotein, is a type of cholesterol that can contribute to plaque buildup in arteries and increase the risk of heart disease and stroke. vi) Cholesterol/High Density Lipoprotein Ratio: The cholesterol ratio, often expressed as the ratio of total cholesterol to high-density lipoprotein (HDL) cholesterol, is a useful measure in assessing cardiovascular risk. This ratio provides additional insights into the balance between "good" and "bad" cholesterol and is considered a valuable tool in predicting the risk of heart disease. vii) LDL/HDL Ratio: The ratio of low-density lipoprotein (LDL) to low-density lipoprotein (HDL) cholesterol is an important indicator of risk for heart disease and stroke.

--End Of Report--
Thyroid Function Test (TFT)
Investigation Result Units Biological Reference Interval

T3 (Triiodothyronine) 1.12 ng/mL 0.8 - 2.0
• Sample Type : Serum.
• Method : ECLIA.
T4 (Thyroxine) 6.41 ug/dl 5.1 - 14.1
• Sample Type : Serum.
• Method : ECLIA.
ULTRA Thyroid Stimulating Hormone (TSH) 3.4 uIU/mL 0.27 - 4.2
Frist trimester: 0.3- 4.5
Second trimester : 0.5 -4.6
Third trimester : 0.8 -5.2
• Sample Type : Serum.
• Method : ECLIA.

1) TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between 6-10 pm. The variation is of the order of 50% . hence time of the day has influence on the measured serum TSH concentrations. 2) Recommended test for T3 and T4 is unbound fraction or free levels as it is metabolically active. 3) Physiological rise in Total T3 / T4 levels is seen in pregnancy and in patients on steroid therapy. Clinical Use : • Primary Hypothyroidism • Hyperthyroidism • Hypothalamic – Pituitary hypothyroidism • Inappropriate TSH secretion • Nonthyroidal illness • Autoimmune thyroid disease • Pregnancy associated thyroid disorders. • References : - Henry’s Clinical Diagnosis and Management, 23rd edition. -Tietz Fundamentals of Clinical Chemistry and Molecular Diagnosis, 7th edition. •Disclaimer: 1) The above result relate only to the specimens received and tested in laboratory and should be always correlate with clinical findings and other laboratory markers. 2) Improper specimen collection, handling,storage and transportation may result in false negative/Positive results.

--End Of Report--
P011B000395958
Download


CBC (Haemogram)
Investigation Result Units Biological Reference Interval

Haemoglobin (Hb) 11.1 gm/dL 12 - 15
Sample Type : EDTA Whole Blood
Method : Free Cyanide
Hematocrit 33.7 % 36 - 46
Sample Type : EDTA Whole Blood
Method : Calculated
RBC Count 4.46 million/cmm 4.5 - 5.5
Sample Type : EDTA Whole Blood
Method : Electrical Impedance
WBC (Total Leukocyte) Count 5400 Cells/cumm 4000 - 10000
Sample Type : EDTA Whole Blood
Method : Flow Cytometry
Platelet Count 231000 /cmm 150000 - 450000
Sample Type : EDTA Whole Blood
Method : Electrical Impedance
CBC (Haemogram)
Investigation Result Units Biological Reference Interval

Manual Platelet Count 00 /cmm
Sample Type : EDTA Whole Blood
Method : Microscopy using Leishman stain
MCV 75.5 fL 83 - 101
Sample Type : EDTA Whole Blood
Method : Calculated
MCH 24.8 pg 27 - 32
Sample Type : EDTA Whole Blood
Method : Calculated
MCHC 32.8 g/dL 31.5 - 34.5
Sample Type : EDTA Whole Blood
Method : Calculated
RDW-CV 15 % 11.6 - 14
Sample Type : EDTA Whole Blood
Method : Calculated
RDW-SD 43.3 fL 35 - 56
Sample Type : EDTA Whole Blood
Method : Calculated
MPV (Mean Platelet Volume) 10.6 fL 6 - 9.5
Sample Type : EDTA Whole Blood
Method : Calculated
PDW (Platelet Distribution Width) 15.8 % 9 - 17
Sample Type : EDTA Whole Blood
Method : Calculated
PCT 0.24 % 0.2 - 0.5
Sample Type : EDTA Whole Blood
Method : Calculated
CBC (Haemogram)
Investigation Result Units Biological Reference Interval

Neutrophils (%) 53.4 % 40 - 80
Sample Type : EDTA Whole Blood
Method : Flow Cytometry
Lymphocytes (%) 41.7 % 20 - 40
Sample Type : EDTA Whole Blood
Method : Flow Cytometry
Monocytes (%) 3.1 % 2 - 10
Sample Type : EDTA Whole Blood
Method : Flow Cytometry
Eosinophils (%) 1.4 % 1 - 6
Sample Type : EDTA Whole Blood
Method : Flow Cytometry
Basophils (%) 0.4 % 0 - 2
Sample Type : EDTA Whole Blood
Method : Flow Cytometry
Absolute Neutrophils Count 2883.6 /c.mm 2000 - 7000
Sample Type : EDTA Whole Blood
Method : Calculated
CBC (Haemogram)
Investigation Result Units Biological Reference Interval

Absolute Lymphocyte Count 2251.8 /c.mm 1000 - 3000
Sample Type : EDTA Whole Blood
Method : Calculated
Absolute Monocyte Count 167.4 /c.mm 200 - 1000
Sample Type: EDTA Whole Blood
Method: Calculated
Absolute Eosinophil Count 75.6 /c.mm 20 - 500
Sample Type : EDTA Whole Blood
Method : Calculated
Absolute Basophil Count 21.6 /c.mm 20 - 100
Sample Type : EDTA Whole Blood
Method : Calculated
Absolute Neutrophil/Lymphocyte Ratio 00 -- --
Sample Type : EDTA Whole Blood
Method : Calculated
Blasts (%) 00 %
Sample Type: EDTA Whole Blood
Method: Microscopy using Leishman stain
Promyelocytes (%) 00 %
Sample Type: EDTA Whole Blood
Method: Microscopy using Leishman stain
Myelocytes (%) 00 %
Sample Type: EDTA Whole Blood
Method: Microscopy using Leishman stain
Metamyelocytes (%) 00 %
Sample Type: EDTA Whole Blood
Method: Microscopy using Leishman stain
CBC (Haemogram)
Investigation Result Units Biological Reference Interval

Band form Cells (%) 00 %
Sample Type: EDTA Whole Blood
Method: Microscopy using Leishman stain
RBC Morphology Mildly Microcytic hypochromic - -
Sample Type: EDTA Whole Blood
Method: Microscopy using Leishman stain
WBC Morphology Total leucocyte count within normal limits - -
Sample Type: EDTA Whole Blood
Method: Microscopy using Leishman stain
Platelets Adequate -- -
Sample Type: EDTA Whole Blood
Method: Microscopy using Leishman stain
CBC (Haemogram)
Clinical Significance:
Test Causes of Low Abnormal Causes of High Abnormal
White blood cell count (WBC) Autoimmune diseases, immunosuppression, bone marrow failure, chemotherapy, viral infections Infection, inflammation, leukemia, intense exercise, stress, corticosteroids
Lymphocytes, absolute (LY, abs) or percentage (LY, pct) Immunosuppression, HIV-AIDS, bone marrow failure, chemotherapy Viral infections, leukemia, lymphoma
Monocytes, absolute (MO, abs) or percentage (MO, pct) Immunosuppression, bone marrow failure, chemotherapy Chronic infections, autoimmune diseases, leukemia
Granulocytes, absolute (GR, abs) or percentage (GR, pct) Immunosuppression, bone marrow failure, chemotherapy Infection, inflammation, leukemia, intense exercise, stress, corticosteroids
Neutrophils, absolute (NE, abs) or percentage (NE, pct) Immunosuppression, bone marrow failure, chemotherapy Infection, inflammation, leukemia, intense exercise, stress, corticosteroids
Eosinophils, absolute (EOS, abs) or percentage (EOS, pct) Sepsis, Alcohol Intoxication, Stress, Increased Cortisol Parasitic infections, Active Allergic Response
Basophils, absolute (BAS, abs) or percentage (BAS, pct) Stress, Chemotherapy, Radiotherapy, Corticosteroid Chronic Inflammation, Autoimmune Disease, Leukemia
Red blood cell count (RBC) Iron, vitamin B12, or folate deficiency; bone marrow damage; leukemia or lymphoma; acute or chronic blood loss; red blood cell hemolysis Dehydration, renal problems, pulmonary disease, congenital heart disease, polycythemia vera
CBC (Haemogram)
Clinical Significance:
Test Causes of Low Abnormal Causes of High Abnormal
Hemoglobin (HgB) Iron, vitamin B12, or folate deficiency; bone marrow damage; leukemia or lymphoma; acute or chronic blood loss; red blood cell hemolysis Dehydration, renal problems, pulmonary disease, congenital heart disease, polycythemia vera
Hematocrit (PCV) Iron, vitamin B12, or folate deficiency; bone marrow damage; leukemia or lymphoma; acute or chronic blood loss; red blood cell hemolysis Dehydration, renal problems, pulmonary disease, congenital heart disease, polycythemia vera
Mean corpuscular volume (MCV) Iron deficiency, Thalassemia, lead poisoning Vitamin B12 or folate deficiency, Chronic liver disease
Mean corpuscular hemoglobin (MCH) Iron deficiency, Thalassemia Vitamin B12 or folate deficiency, Macrocytosis
Mean corpuscular hemoglobin concentration (MCHC) Iron deficiency, Thalassemia Sickle cell disease, hereditary spherocytosis
Red cell distribution width (RDW) Generally not a concern Iron deficiency, vitamin B12 or folate deficiency, recent blood loss
Platelet count (PLT) Bone marrow failure, chemotherapy, viral infections, lupus, pernicious anemia (due to vitamin B12 deficiency), leukemia or lymphoma, sequestration in the spleen, certain medications Leukemia, myeloproliferative disorders (which cause blood cells to grow abnormally in bone marrow), inflammatory conditions
Mean platelet volume (MPV) Aplastic anemia, thrombocytopenia, bone marrow suppression Certain inherited disorders

Disclaimer: The above result relate only to the specimens and should be always correlate with clinical findings and other laboratory markers.

--End Of Report--